Clinical Trial
Agios Pharmaceuticals’ Lead Candidate Mitapivat Achieves Primary Endpoint in ACTIVATE Trial
2020-12-03
Over 1000 Pharma & Biotech players across Asia and beyond to gather virtually in December!
2020-11-27
Xofluza Garners FDA Approval for Influenza Prevention Following Contact with Infected Patients
2020-11-26
Gilead and Novo Nordisk Present Proof-of-Concept Data for the First Possible NASH Treatment
2020-11-17